≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Oesophageal obstruction

DOID EFO Endpoint Browser PheWeb

K11_OESOBST

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K22.2
  • Hospital discharge: ICD-9 — 5303
  • Hospital discharge: ICD-8 — 5303
  • Cause of death: ICD-10 — K22.2
  • Cause of death: ICD-9 — 5303
  • Cause of death: ICD-8 — 5303

2 out of 7 registries used, show all original rules.

1313

4. Check minimum number of events

None

1313

5. Include endpoints

None

1313

6. Filter based on genotype QC (FinnGen only)

1313

Control definitions (FinnGen only)

Control exclude
K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K22
Name in latin
Obstructio oesophagi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10378 4277 5966
Only index persons 7927 3308 4619
Unadjusted period prevalence (%)
Whole population 0.15 0.12 0.17
Only index persons 0.15 0.12 0.18
Median age at first event (years)
Whole population 67.37 70.35 65.19
Only index persons 66.11 68.96 64.07

-FinnGen-

Key figures

All Female Male
Number of individuals 1313 510 803
Unadjusted period prevalence (%) 0.28 0.17 0.35
Median age at first event (years) 66.20 65.03 66.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1187
Matched controls
11871
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K22.2
ICD-10 Finland
Oesophageal obstruction
4503599627370496.0
323.0
1155
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
87.5
323.0
378
63
R13
ICD-10 Finland
Dysphagia
32.2
323.0
489
252
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
38.7
323.0
954
1135
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
1013.9
323.0
486
8
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
64.2
183.3
212
40
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
18.3
172.5
279
196
UJC12
NOMESCO Finland
Flexible oesophagoscopy
115.7
157.8
169
17
T18.1
ICD-10 Finland
Foreign body in oesophagus
118.7
153.5
164
16
K22.1
ICD-10 Finland
Ulcer of oesophagus
1608.0
148.1
141
*
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
86.9
143.6
159
21
UJD02
NOMESCO Finland
Gastroscopy
21.7
143.5
216
120
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
91.7
131.7
145
18
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
21.6
129.5
195
107
A02BC05
ATC
esomeprazole; systemic
4.1
110.2
651
2720
A02BC02
ATC
pantoprazole; systemic
4.3
105.8
931
5441
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
27.4
93.6
130
53
K22.0
ICD-10 Finland
Achalasia of cardia
+∞
90.8
86
*
UJC02
NOMESCO Finland
Rigid oesophagoscopy
71.0
86.0
98
15
K20
ICD-10 Finland
Oesophagitis
78.8
78.4
88
12
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
42.1
77.7
97
25
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
211.2
77.2
79
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
684.6
66.6
65
*
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
651.1
63.4
62
*
A02BC03
ATC
lansoprazole; oral
3.1
61.6
444
1910
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
24.1
55.2
79
35
5303A
ICD-9 Finland
Diseases of oesophagus, Stricture and stenosis of oesophagus[STRICTURA ET STENOSIS OESOPHAGI]
+∞
54.6
52
*
K22.7
ICD-10 Finland
Barrett oesophagus
113.0
50.2
54
5
JDB10
NOMESCO Finland
Percutaneous gastrostomy
17.5
49.7
79
48
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
173.7
48.2
50
*
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
166.4
46.1
48
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
56.4
45.9
54
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
44.8
318
1304
K22.8
ICD-10 Finland
Other specified diseases of oesophagus
442.9
43.5
43
*
A02BC01
ATC
omeprazole; systemic
2.6
43.0
399
1917
K22.3
ICD-10 Finland
Perforation of oesophagus
+∞
41.9
40
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
41.8
405
1989
A02BA02
ATC
ranitidine; systemic
2.9
41.2
304
1269
R11
ICD-10 Finland
Nausea and vomiting
4.6
39.5
146
349
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
39.5
316
1380
K92.0
ICD-10 Finland
Haematemesis
12.5
38.5
70
59
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
37.2
603
3766
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
36.2
411
2161
TJD20
NOMESCO Finland
Change of gastrostomy tube
36.7
36.1
46
13
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
44.5
35.2
43
10
R4190
NOMESCO Finland
Nutritional therapy
7.8
34.6
82
112
1323
FHL
Esophagoscopy and dilatation
+∞
33.5
32
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
32.8
266
1154
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
31.6
311
1499
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
43.5
31.0
38
9
K29.3
ICD-10 Finland
Chronic superficial gastritis
52.9
30.5
36
7
WX002
NOMESCO Finland
Sedation and analgesia
2.5
30.4
293
1393
UJF32
NOMESCO Finland
Coloscopy
2.3
30.4
332
1685
K22.5
ICD-10 Finland
Diverticulum of oesophagus, acquired
+∞
29.3
28
*
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
+∞
29.3
28
*
W44
ICD-10 Finland
Foreign body entering into or through eye or natural orifice
9.8
28.9
59
63
JN4BD
NOMESCO Finland
Extensive body CT
2.9
28.3
196
768
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
287.8
27.9
28
*
N02AA05
ATC
oxycodone; systemic
2.5
27.8
243
1092
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
27.5
122
344
D21
ICPC
Swallowing problem
9.9
26.6
54
57
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
26.5
118
333
A07AA02
ATC
nystatin; oral
3.7
25.4
118
345
UJC01
NOMESCO Finland
Scopy of lower throat
12.6
24.7
44
36
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
24.5
259
1276
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
57.2
24.1
28
5
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.9
24.1
102
276
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
23.9
147
530
A02BC04
ATC
rabeprazole; oral
3.8
23.7
104
290
130
Kela drug reimbursment
Malignant tumour
2.8
23.4
166
655
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.1
23.4
76
158
K29.7
ICD-10 Finland
Gastritis, unspecified
13.9
22.8
39
29
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.7
22.8
67
124
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
23.4
22.6
32
14
WX402
NOMESCO Finland
General anaesthesia
2.4
22.5
216
1010
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
45.9
22.4
27
6
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
22.2
355
2079
1320
FHL
Esophagoscopy
24.4
22.2
31
13
N06AX11
ATC
mirtazapine; oral
2.0
22.2
367
2178
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
29.7
21.9
29
10
D84
ICPC
Oesophagus disease
63.7
21.9
25
*
A03FA02
ATC
cisapride; oral, rectal
3.2
21.7
122
412
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.6
21.4
100
294
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
9.3
21.2
44
49
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
51.0
21.2
25
5
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
21.2
231
1145
53091
ICD-8 Finland
Diseases of oesophagus, Strictura
+∞
20.9
20
*
J01MA12
ATC
levofloxacin; systemic
2.1
20.7
269
1442
N05CF01
ATC
zopiclone; oral
1.9
20.6
409
2582
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.8
20.3
90
253
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
20.3
141
548
N03AX16
ATC
pregabalin; oral
2.1
19.9
279
1541
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
58.5
19.9
23
*
6241
FHL
Fund application (Nissen)
+∞
19.8
19
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
19.7
253
1347
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.3
19.7
104
337
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
19.1
226
1161
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
19.0
149
620
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.0
18.9
78
206
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
18.5
91
279
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.3
18.2
56
110
XJC00
NOMESCO Finland
Oesophageal manometry
+∞
17.7
17
*
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
+∞
17.7
17
*
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
+∞
17.7
17
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
17.5
82
242
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
10.9
17.5
33
31
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
7.4
17.3
41
57
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
17.2
74
204
K30
ICD-10 Finland
Functional dyspepsia
3.4
17.1
86
268
Z43.1
ICD-10 Finland
Attention to gastrostomy
50.7
17.0
20
*
RD210
NOMESCO Finland
NA
8.8
17.0
36
42
K92.1
ICD-10 Finland
Melaena
3.7
17.0
75
211
JCE21
NOMESCO Finland
Laparoscopic cardiomyotomy
+∞
16.7
16
*
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
35.6
16.7
21
6
A02BA04
ATC
nizatidine; systemic
2.8
16.7
110
414
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
172.2
16.5
17
*
JDB00
NOMESCO Finland
Gastrostomy
28.0
16.5
22
8
A04AA01
ATC
ondansetron; systemic, rectal
3.0
16.0
97
346
GBB00
NOMESCO Finland
Tracheostomy
8.2
15.8
35
44
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
60.8
15.8
18
*
R4110
NOMESCO Finland
Physiotherapy
1.8
15.8
321
2009
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
15.6
108
419
B03BA03
ATC
hydroxocobalamin; parenteral
3.0
15.4
90
313
H02AB06
ATC
prednisolone; systemic
1.7
15.0
526
3858
R53
ICD-10 Finland
Malaise and fatigue
1.9
14.8
236
1353
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
25.4
14.7
20
8
K29.4
ICD-10 Finland
Chronic atrophic gastritis
21.3
14.7
21
10
T28.6
ICD-10 Finland
Corrosion of oesophagus
+∞
14.6
14
*
JBC00
NOMESCO Finland
Gastro-oesophageal antireflux operation
81.1
14.6
16
*
TJF00
NOMESCO Finland
Insertion of jejunal tube
81.1
14.6
16
*
JFF00
NOMESCO Finland
Catheter enterostomy
151.7
14.5
15
*
K29.8
ICD-10 Finland
Duodenitis
151.7
14.5
15
*
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
27.5
14.3
19
7
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
14.2
134
614
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.2
13.9
33
47
SPAT1254
SPAT
Administration of medicine
2.0
13.8
191
1035
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
13.8
366
2471
J01DB01
ATC
cefalexin; oral
1.7
13.7
881
7507
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.2
13.7
52
129
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
+∞
13.6
13
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.7
13.5
38
68
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.0
13.5
43
89
Z51.5
ICD-10 Finland
Palliative care
2.6
13.5
98
391
T05
ICPC
Feeding problem of adult
16.4
13.5
21
13
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.8
13.3
33
50
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
13.3
376
2575
N02AX02
ATC
tramadol; systemic, rectal
1.6
13.2
483
3542
GBB13
NOMESCO Finland
Revision of tracheostomy
40.5
13.2
16
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
13.0
355
2405
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
12.9
193
1078
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
12.8
150
758
JN4CD
NOMESCO Finland
Very extensive body CT
3.0
12.8
73
250
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
12.7
77
273
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
70.6
12.6
14
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
12.5
110
485
C16.00
ICD-10 Finland
Cardia
17.5
12.5
19
11
JCC30
NOMESCO Finland
Transthoracic partial oesophagectomy with interposition of intestine
+∞
12.5
12
*
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
+∞
12.5
12
*
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
+∞
12.5
12
*
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
+∞
12.5
12
*
P01AB01
ATC
metronidazole; oral, rectal
1.6
12.5
381
2656
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
12.3
219
1298
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
12.2
208
1213
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
12.1
149
768
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
7.0
12.1
29
42
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
27.0
12.1
16
6
JAH00
NOMESCO Finland
Laparotomy
3.8
11.7
49
133
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
11.7
125
607
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
11.6
254
1608
R06.0
ICD-10 Finland
Dyspnoea
1.7
11.6
283
1847
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
11.6
57
177
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.3
11.5
34
65
5308A
ICD-9 Finland
Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]
+∞
11.5
11
*
JCA96
NOMESCO Finland
Other local operation on oesophagus
+∞
11.5
11
*
JCF00
NOMESCO Finland
Insertion of prosthetic tube into oesphagus
+∞
11.5
11
*
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
+∞
11.5
11
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
11.5
152
808
H02AB02
ATC
dexamethasone; systemic
2.1
11.3
128
637
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
9.0
11.3
23
26
C15.0
ICD-10 Finland
Malignant neoplasm: Cervical part of oesophagus
35.4
11.3
14
*
RD160
NOMESCO Finland
NA
35.4
11.3
14
*
J02AC01
ATC
fluconazole; systemic
1.6
11.2
335
2307
A06AD11
ATC
lactulose; oral
1.9
11.2
188
1088
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.1
11.1
34
68
A02BDXX
ATC
NA
3.7
11.1
48
135
WX600
NOMESCO Finland
Single shot through catheter
6.0
10.9
29
49
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.9
10.8
43
112
X58
ICD-10 Finland
Exposure to other specified factors
2.0
10.8
147
787
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
10.8
145
776
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.9
10.8
29
50
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
10.7
94
416
J01MA02
ATC
ciprofloxacin; systemic
1.5
10.7
444
3310
A28
ICPC
Limited function/disability NOS
1.8
10.7
199
1194
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.8
10.6
67
247
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.1
10.6
40
100
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
3.7
10.5
45
126
R03BB04
ATC
tiotropium bromide; inhalant
2.0
10.4
135
711
R03AC02
ATC
salbutamol; inhalant
1.5
10.4
514
3981
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
110.9
10.4
11
*
C15.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oesophagus
110.9
10.4
11
*
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
110.9
10.4
11
*
A02BX02
ATC
sucralfate; oral
3.1
10.4
57
192
N07BB01
ATC
disulfiram; oral
3.2
10.3
54
176
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
10.3
145
788
SPAT1125
SPAT
Stoma care and guidance
4.2
10.3
38
93
UGB02
NOMESCO Finland
Tracheoscopy
23.6
10.2
14
6
N05CD07
ATC
temazepam; oral
1.9
10.2
164
936
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
10.1
95
435
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
10.1
286
1934
H02AB07
ATC
prednisone; oral
1.9
10.0
158
897
L28
ICPC
Limited function/disability (L)
1.8
9.9
192
1164
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
26.2
9.8
13
5
K29.1
ICD-10 Finland
Other acute gastritis
20.2
9.8
14
7
R12
ICD-10 Finland
Heartburn
2.7
9.8
66
254
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
9.6
134
723
A01AB09
ATC
miconazole; local oral
2.1
9.6
105
513
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.3
9.5
86
387
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
9.4
158
911
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
30.2
9.4
12
*
53094
ICD-8 Finland
Diseases of oesophagus, Oesophagitis
+∞
9.4
9
*
WZC30
NOMESCO Finland
Teaching
1.8
9.3
154
887
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
9.3
66
262
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
9.3
96
460
WX892
NOMESCO Finland
Monitored bed care
2.1
9.0
101
499
XJC10
NOMESCO Finland
Oesophageal pH monitoring
37.0
9.0
11
*
WX110
NOMESCO Finland
Local anesthesy
1.5
9.0
674
5630
JBB01
NOMESCO Finland
Laparoscopic repair of paraoesophageal hernia
18.7
8.9
13
7
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.5
8.9
68
281
R51.80
ICD-10 Finland
Headache
2.0
8.9
117
617
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
24.2
8.9
12
5
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
8.9
68
282
107
Kela drug reimbursment
Pernicious anaemia
4.1
8.9
33
82
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.8
8.9
56
207
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.9
8.9
35
92
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.8
457
3542
N05BA04
ATC
oxazepam; oral
1.6
8.8
243
1628
B81
ICPC
Anaemia vit B12/folate deficiency
3.0
8.7
50
173
J01FF01
ATC
clindamycin; systemic
1.6
8.7
276
1913
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.6
8.7
38
109
Z93.1
ICD-10 Finland
Gastrostomy status
50.3
8.7
10
*
K22
ICD-10 Finland
Other diseases of oesophagus
50.3
8.7
10
*
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
50.3
8.7
10
*
ZX120
NOMESCO Finland
Intravenous
2.0
8.6
107
554
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
8.5
74
327
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
8.5
94
465
JF1AD
NOMESCO Finland
Small bowel CT
27.7
8.5
11
*
JCB00
NOMESCO Finland
Oesophagostomy
90.6
8.4
9
*
GBB96
NOMESCO Finland
Other tracheostomy procedure
90.6
8.4
9
*
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
90.6
8.4
9
*
K26.7
ICD-10 Finland
Duodenal ulcer, chronic without haemorrhage or perforation
90.6
8.4
9
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
8.4
81
377
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
8.4
121
666
JCE00
NOMESCO Finland
Suture of oesophagus
+∞
8.3
8
*
JCD03
NOMESCO Finland
Subcutaneous anastomosis of oesophagus with interposition of intestine
+∞
8.3
8
*
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
+∞
8.3
8
*
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
+∞
8.3
8
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.7
8.3
56
214
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
2.9
8.3
49
175
K44
ICD-10 Finland
Diaphragmatic hernia
9.5
8.3
16
17
N05AH04
ATC
quetiapine; oral
1.8
8.3
145
850
1310
FHL
Esophagogastroscopy
14.6
8.2
13
9
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
8.2
77
354
N05BA02
ATC
chlordiazepoxide; systemic
3.8
8.2
33
89
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
8.2
8.1
17
21
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.7
8.1
33
90
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
8.1
65
277
SPAT1263
SPAT
Sampling
1.4
8.0
439
3419
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
10.1
8.0
15
15
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.0
146
865
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.0
7.9
24
49
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
6.6
7.9
19
29
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.4
7.8
22
41
F10.24
ICD-10 Finland
Alcohol depence active use
5.8
7.8
21
37
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.5
7.8
26
59
J01MA14
ATC
moxifloxacin; systemic
2.0
7.7
98
510
B01AB05
ATC
enoxaparin; parenteral
1.5
7.7
337
2504
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
15.1
7.7
12
8
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
45.2
7.7
9
*
K08.3
ICD-10 Finland
Retained dental root
2.1
7.7
85
419
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
6.0
7.7
20
34
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.7
123
702
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
7.6
54
216
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
18.5
7.6
11
6
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.6
111
613
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
7.5
177
1135
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.5
7.5
25
57
N06AB04
ATC
citalopram; systemic
1.6
7.5
203
1353
ZXC10
NOMESCO Finland
Use of laser
3.4
7.5
34
102
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.4
267
1898
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
80.5
7.4
8
*
8070/3-C15.4
ICD-O-3
Squamous cell carcinoma, NOS, of middle third of esophagus
80.5
7.4
8
*
JBW97
NOMESCO Finland
Other laparoscopic operation on diaphragm or laparoscopic or thoracoscopic operation for gastro-oesophageal reflux
80.5
7.4
8
*
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
80.5
7.4
8
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.5
7.4
32
92
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.8
7.3
23
49
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.3
474
3796
JCE96
NOMESCO Finland
Other reconstruction of oesophagus
+∞
7.3
7
*
JCA42
NOMESCO Finland
Other endoscopic procedure for hemostasis
+∞
7.3
7
*
K31.5
ICD-10 Finland
Obstruction of duodenum
+∞
7.3
7
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
7.3
7
*
K29.2
ICD-10 Finland
Alcoholic gastritis
+∞
7.3
7
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.3
89
461
Z50.1
ICD-10 Finland
Other physical therapy
2.3
7.3
63
280
N06AB10
ATC
escitalopram; oral
1.7
7.2
157
986
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
7.2
79
389
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.1
382
2947
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.1
145
889
Z53.0
ICD-10 Finland
Procedure not carried out because of contraindication
20.1
7.1
10
5
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.3
7.1
20
38
93500
ICD-8 Finland
Foreign body in mouth, oesophagus and stomach
12.1
7.1
12
10
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
12.1
7.1
12
10
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
7.1
79
394
A04AA02
ATC
granisetron; systemic, transdermal
2.2
7.0
69
325
WF004
NOMESCO Finland
Palliative radiotherapy
3.2
7.0
35
113
N02BE01
ATC
paracetamol; systemic, rectal
1.5
7.0
931
8452
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.0
7.0
38
130
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.6
7.0
49
195
P15
ICPC
Chronic alcohol abuse
3.4
6.9
31
92
E87.6
ICD-10 Finland
Hypokalaemia
2.8
6.9
41
148
W19
ICD-10 Finland
Unspecified fall
1.9
6.9
102
566
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
6.9
73
356
A11CC02
ATC
dihydrotachysterol; oral
13.9
6.9
11
8
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
6.9
172
1119
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.8
6.9
21
44
N06AB03
ATC
fluoxetine; oral
1.8
6.8
116
675
C07AB07
ATC
bisoprolol; oral
1.4
6.8
545
4510
9351A
ICD-9 Finland
Foreign body in mouth, oesophagus and stomach, Oesophagus
11.0
6.8
12
11
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
6.8
87
458
N05AH03
ATC
olanzapine; systemic
2.4
6.8
55
238
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
6.8
55
238
1322
FHL
Esophagoscopy and foreign object removal
40.3
6.8
8
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.1
6.8
76
378
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
22.6
6.7
9
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.0
6.6
35
118
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.2
6.6
23
55
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.5
6.6
47
189
A02BA03
ATC
famotidine; systemic
2.5
6.6
47
189
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
5.9
6.6
17
29
R03BA05
ATC
fluticasone; inhalant
1.6
6.6
162
1050
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.8
6.6
39
141
JN4AD
NOMESCO Finland
Body CT examination
1.9
6.6
90
487
SPAT1279
SPAT
Preparation of immediate hospitalisation
4.8
6.5
20
42
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.5
374
2913
R4130
NOMESCO Finland
Speech therapy
3.3
6.5
31
97
A04
ICPC
Weakness/tiredness general
1.7
6.5
131
801
D10
ICPC
Vomiting
2.8
6.5
39
143
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
6.5
70
345
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
6.4
220
1544
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
6.4
43
168
SPAT1124
SPAT
Replacement of gastrostomy tube
70.2
6.4
7
*
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
70.2
6.4
7
*
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
70.2
6.4
7
*
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
70.2
6.4
7
*
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
70.2
6.4
7
*
WX704
NOMESCO Finland
Intubation
2.0
6.4
74
374
J37.0
ICD-10 Finland
Chronic laryngitis
3.1
6.4
32
104
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.7
6.4
39
145
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.2
6.3
30
94
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.4
6.3
51
219
ZZR10
NOMESCO Finland
Flap of skin and muscle
6.0
6.3
16
27
UGC02
NOMESCO Finland
Rigid bronchoscopy
9.3
6.3
12
13
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
18.1
6.3
9
5
M01AB55
ATC
diclofenac, combinations; oral
2.0
6.3
77
400
J38.6
ICD-10 Finland
Stenosis of larynx
+∞
6.3
6
*
1314
FHL
Esophagogastroscopy and other therapeutic procedure
+∞
6.3
6
*
5322B
ICD-9 Finland
Duodenal ulcer, Acute with haemorrhage and perforation[ULCUS BULBI,VUOTAVA]
+∞
6.3
6
*
5300A
ICD-9 Finland
Diseases of oesophagus, Achalasia and cardiospasm
+∞
6.3
6
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
6.2
122
742
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.1
6.2
18
36
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
6.2
90
496
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
6.2
202
1405
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
6.2
65
315
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.2
76
394
D07AC01
ATC
betamethasone; topical
1.4
6.2
338
2608
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.1
6.1
63
304
H25.8
ICD-10 Finland
Other senile cataract
1.7
6.1
131
818
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
2.0
6.1
72
368
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
7.7
6.1
13
17
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
6.1
176
1188
ZZA00
NOMESCO Finland
Split skin graft
2.7
6.1
40
154
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.1
158
1037
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
12.6
6.1
10
8
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
8.6
6.1
12
14
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
8.6
6.1
12
14
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.3
6.0
52
231
K44.0
ICD-10 Finland
Diaphragmatic hernia with obstruction, without gangrene
10.1
6.0
11
11
H02AB09
ATC
hydrocortisone; systemic
3.5
6.0
26
76
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.0
103
599

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
485
924
7.74
264.13
2.0
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
769
4599
2.62
62.62
9.5
11.0
inr
1.2
1.3
7.30
173
1289
(3044640) Blood type and Crossmatch panel - Blood
593
3230
2.52
57.39
4.5
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
758
4641
2.50
56.58
7.7
4.6
g/l
33.9
34.9
5.45
718
4272
(3003458) Phosphate [Moles/volume] in Serum or Plasma
323
1442
2.64
45.79
6.0
5.4
mmol/l
1.0
1.0
0.10
304
1327
(3012095) Magnesium [Moles/volume] in Serum or Plasma
365
1744
2.51
44.80
4.4
3.2
mmol/l
0.8
0.8
4.66
349
1618
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
461
2464
2.34
43.90
3.8
2.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
482
2627
2.32
43.84
2.7
2.1
mg/l
3.1
3.0
0.31
413
2186
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
526
2991
2.27
43.06
3.3
2.3
u/l
57.0
57.8
0.20
477
2733
(3013826) Glucose [Moles/volume] in Serum or Plasma
880
6216
2.26
41.23
8.0
4.7
mmol/l
6.7
6.8
0.57
847
5843
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
784
5320
2.18
40.18
8.2
6.2
umol/l
11.1
12.1
1.54
754
5042
(3023368) Bacteria identified in Blood by Culture
533
3170
2.15
37.82
5.5
4.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
196
746
2.91
37.23
1.8
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
703
4802
2.00
32.67
5.7
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
532
3312
2.02
32.05
6.0
5.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
750
5327
1.95
30.15
9.7
6.7
mmol/l
1.2
1.2
1.49
638
4429
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
219
976
2.49
30.10
2.4
1.9
g/l
0.2
0.2
1.99
205
900
(3022948) Iron [Moles/volume] in Serum or Plasma
315
1649
2.20
29.78
2.6
2.4
umol/l
11.0
12.8
4.40
284
1532
(3001122) Ferritin [Mass/volume] in Serum or Plasma
590
3881
1.94
29.68
3.3
2.6
ug/l
127.7
164.4
3.23
536
3515
(3019069) Monocytes/100 leukocytes in Blood
659
4539
1.91
28.46
6.8
6.1
%
8.8
8.9
0.64
615
4227
(3006504) Eosinophils/100 leukocytes in Blood
656
4518
1.90
28.27
6.4
5.8
%
2.9
2.9
0.23
613
4191
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
646
4441
1.89
27.86
2.4
2.0
pmol/l
90.4
93.5
0.90
371
2288
(3002030) Lymphocytes/100 leukocytes in Blood
666
4627
1.89
27.77
6.8
6.0
%
23.7
26.4
7.58
618
4284
(3022096) Basophils/100 leukocytes in Blood
639
4390
1.89
27.50
6.6
5.8
%
0.6
0.7
0.24
597
4075
(3018010) Neutrophils/100 leukocytes in Blood
655
4543
1.88
27.29
6.5
5.8
%
60.4
58.2
4.09
611
4238
(3004789) Transferrin [Mass/volume] in Serum or Plasma
289
1515
2.16
26.94
2.4
2.4
g/l
2.3
2.3
0.29
266
1404
(3019309) Folate [Moles/volume] in Red Blood Cells
371
2142
2.02
26.68
2.1
1.8
nmol/l
1178.0
1175.6
0.02
278
1573
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
988
7908
2.01
25.71
10.1
7.4
u/l
88.3
79.3
1.37
939
7397
(3006315) Basophils [#/volume] in Blood
678
4820
1.84
25.49
5.9
5.6
e9/l
0.0
0.0
1.03
588
4098
(3013115) Eosinophils [#/volume] in Blood
694
4986
1.83
25.05
6.2
5.8
e9/l
0.2
0.2
0.77
597
4302
(3013650) Neutrophils [#/volume] in Blood by Automated count
768
5695
1.84
24.95
10.0
9.0
e9/l
4.6
4.3
2.48
681
4912
(3033658) Prothrombin time (PT) actual/Normal
420
2598
1.91
24.30
6.0
3.9
%
87.6
86.0
0.70
410
2534
(3019198) Lymphocytes [#/volume] in Blood
684
4922
1.81
24.27
6.2
5.6
e9/l
1.7
2.0
2.20
591
4255
(3001604) Monocytes [#/volume] in Blood
671
4801
1.81
24.26
5.9
5.6
e9/l
0.6
0.6
2.01
585
4068
(3020779) Urea [Moles/volume] in Serum or Plasma
206
987
2.29
23.72
6.1
6.6
mmol/l
9.3
10.8
2.24
196
926
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
269
1434
2.10
23.72
2.4
2.5
%
20.5
22.8
1.76
219
1230
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
673
4864
1.79
23.12
8.6
6.0
mmol/l
1.2
1.2
3.18
606
4358
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
320
1866
1.95
21.75
1.9
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
462
3060
1.79
20.79
3.3
3.1
u/l
40.3
34.5
0.34
443
2917
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
148
655
2.42
20.31
1.7
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
213
1132
2.05
18.59
3.7
4.3
ug/l
93.0
14.3
0.67
186
938
(3027945) Reticulocytes/100 erythrocytes in Blood
233
1286
1.99
18.28
2.2
2.4
%
1.8
1.8
0.04
190
1135
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
178
893
2.15
18.07
3.1
2.3
u/l
38.3
43.7
0.29
151
749
(3015377) Calcium [Moles/volume] in Serum or Plasma
511
3607
1.68
17.59
3.6
3.4
mmol/l
2.3
2.4
3.01
436
3111
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
765
6009
1.65
17.19
3.8
2.9
u/l
55.5
54.0
0.16
700
5511
(3021960) Folate [Moles/volume] in Serum or Plasma
394
2611
1.73
17.02
1.7
1.6
nmol/l
20.3
20.2
0.03
338
2187
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
545
3970
1.64
16.24
2.5
2.1
nmol/l
76.9
78.1
0.43
482
3450
(40768804) Tissue Pathology biopsy report
538
3919
1.63
15.95
2.5
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
195
1065
1.98
15.62
3.0
2.5
umol/l
10.0
9.5
0.09
167
944
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
331
2137
1.73
15.48
4.3
3.9
ng/l
1297.5
889.3
0.18
282
1798
(3007853) Bacteria identified in Skin by Aerobe culture
213
1210
1.91
15.17
2.2
1.7
—
—
—
0
0
(3013512) EKG study
450
3169
1.64
15.08
5.2
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
561
4176
1.60
14.93
4.7
3.7
ng/l
38.8
71.9
1.69
445
3130
(3014111) Lactate [Moles/volume] in Serum or Plasma
180
976
1.98
14.68
9.6
7.0
mmol/l
1.4
1.4
0.14
171
940
(40758558) Short blood count panel - Blood
361
2435
1.67
14.17
7.8
6.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
252
1541
1.79
14.10
2.4
2.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
189
1058
1.92
14.01
5.0
3.4
kpa
5.8
5.8
0.01
183
1022
(3023520) Reticulocytes [#/volume] in Blood
176
968
1.94
13.74
2.2
2.5
e9/l
69.1
67.6
0.21
138
733
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
91
385
2.47
13.72
3.3
3.3
u/ml
1826.3
10277.3
0.60
81
324
(3002032) Base excess in Venous blood by calculation
187
1053
1.90
13.60
5.0
3.4
mmol/l
2.2
2.0
0.23
158
830
(3037467) Urinalysis macro (dipstick) panel - Urine
845
7007
1.58
13.51
5.1
4.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
218
1307
1.80
12.96
1.9
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
219
1320
1.79
12.78
10.3
7.2
mmol/l
1.4
1.2
0.31
183
1019
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
218
1316
1.79
12.64
1.9
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
137
715
2.02
12.39
1.8
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
217
1319
1.77
12.27
10.6
7.2
kpa
11.5
12.0
0.96
209
1262
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
217
1319
1.77
12.27
10.6
7.2
kpa
5.1
5.1
0.10
210
1263
(4035726)
164
914
1.91
12.26
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
98
452
2.26
12.17
1.8
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
272
1766
1.68
12.12
3.4
3.0
e6/l
2.4
1.9
0.61
173
1013
(3000570) Elastase.pancreatic [Mass/mass] in Stool
65
249
2.69
12.02
1.5
1.4
ug/g
255.4
278.3
0.46
43
148
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
91
411
2.30
11.87
1.7
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
211
1286
1.76
11.80
3.5
4.3
u/l
240.8
257.8
0.69
196
1219
(3019225) pH of Specimen
181
1054
1.83
11.78
4.8
4.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
56
201
2.87
11.70
1.6
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
197
1180
1.79
11.68
1.6
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
261
1699
1.67
11.46
2.0
2.0
s
29.5
30.1
0.84
254
1643
(3023183) Ammonium ion [Moles/volume] in Plasma
58
215
2.78
11.43
2.9
2.2
umol/l
28.6
34.4
1.39
47
178
(3013707) Erythrocyte sedimentation rate by Westergren method
869
7396
1.52
11.14
4.5
3.9
mm/h
16.0
13.5
3.73
788
6748
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
100
486
2.14
10.93
2.4
1.9
ug/l
1.0
2.5
0.83
94
425
(3026008) Bacteria identified in Urine by Culture
437
3244
1.52
10.88
3.4
3.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
194
1185
1.75
10.71
11.4
7.6
%
95.9
95.4
0.79
187
1147
(3024354) Oxygen [Partial pressure] in Venous blood
152
866
1.85
10.58
4.4
2.7
kpa
4.3
4.4
0.27
146
835
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1106
9985
1.68
10.58
29.1
15.2
mg/l
28.2
27.0
0.59
1008
7940
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
440
3290
1.51
10.50
2.5
2.1
u/l
226.0
228.1
0.02
416
3064
(3000991) Gas panel - Venous blood
160
931
1.82
10.41
12.5
8.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
102
3.50
10.34
3.5
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
83
385
2.23
10.19
5.2
4.1
mmol/l
24.9
24.9
0.04
76
351
(3048689) Calprotectin [Mass/mass] in Stool
151
871
1.83
10.10
2.1
2.1
ug/g
194.5
158.6
0.67
120
682
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
70
307
2.35
9.79
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
297
2066
1.57
9.78
1.8
1.7
mg/l
1.7
1.3
1.18
240
1628
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
275
1885
1.58
9.64
3.1
2.8
e6/l
1.4
1.2
0.16
170
1126
(3003181) Sodium [Moles/volume] in Urine
49
183
2.74
9.56
1.8
1.3
mmol/l
52.3
62.5
0.84
39
151
(3025468) Yersinia sp identified in Specimen by Organism specific culture
36
115
3.19
9.24
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
36
115
3.19
9.24
1.6
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
36
116
3.16
9.11
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
116
637
1.90
9.04
4.6
3.7
mmol/l
1.9
2.0
0.07
89
465
(3018418) pH of Serum or Plasma
420
3187
1.47
9.04
5.2
4.2
ph
7.4
7.4
1.38
77
634
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
502
3956
1.44
8.78
4.0
3.2
—
—
—
0
0
(3026782) Osmolality of Urine
306
2190
1.52
8.75
3.2
2.8
mosm/kgh2o
545.1
560.0
0.51
263
1868
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
94
3.35
8.65
3.4
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
230
1550
1.59
8.60
23.8
28.6
inr
1.4
1.4
0.22
32
213
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
111
611
1.89
8.59
12.3
10.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
445
3445
1.44
8.51
2.9
3.1
ng/l
1930.9
1716.0
0.42
384
2979
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
117
3.05
8.35
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
118
3.02
8.23
1.6
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
136
808
1.76
8.23
3.6
3.7
ng/l
94.6
97.5
0.11
112
693
(3009343) pH of Capillary blood
117
672
1.81
7.93
4.7
3.7
ph
7.4
7.4
—
8
87
(3051651) Icteric interference index of Serum or Plasma
23
61
3.82
7.81
3.7
4.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
105
586
1.86
7.80
13.5
9.8
mmol/l
24.9
24.4
0.62
100
548
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
54
235
2.35
7.74
1.8
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
429
3348
1.42
7.69
3.9
3.3
e6/l
68.7
86.9
0.31
352
2641
(3052851) Hemolysis interference index of Serum or Plasma
65
307
2.18
7.68
3.7
3.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
117
680
1.79
7.63
4.8
3.7
kpa
5.2
5.1
0.08
110
616
(3036481) Cortisol [Moles/volume] in Serum or Plasma
133
804
1.73
7.57
2.4
2.3
nmol/l
433.2
375.0
0.85
127
730
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
76
386
2.03
7.45
3.6
2.7
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
37
4.64
7.41
3.1
1.4
umol/l
57.5
63.8
0.14
11
25
(3022313) Gas panel - Capillary blood
88
472
1.93
7.39
4.8
3.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
291
2129
1.47
7.33
3.9
3.1
mmol/l
2.5
2.5
0.66
252
1878
(1616796) Gas panel - Central venous blood
54
241
2.29
7.32
3.3
4.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
96
533
1.86
7.26
1.7
1.8
g/l
1.6
1.6
0.11
85
458
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
19
6.36
7.25
1.1
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
87
471
1.91
7.11
6.0
5.0
%
1.6
1.6
0.15
82
445
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
82
438
1.93
6.98
2.5
2.6
u/ml
0.3
0.4
0.95
38
249
(3030467) Casts [#/volume] in Urine by Automated count
393
3063
1.40
6.97
3.7
3.2
e6/l
0.5
0.5
0.00
310
2376
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
188
1267
1.56
6.96
4.9
4.7
%
33.9
32.8
0.54
122
784
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
238
1695
1.49
6.82
1.3
1.2
u/ml
2.1
1.9
0.11
62
443
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
157
1020
1.61
6.79
2.5
2.4
ug/l
5.0
7.5
2.12
137
898
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
494
1.86
6.75
2.8
2.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
93
526
1.83
6.65
5.1
3.8
mmol/l
24.1
24.2
0.04
87
470
(3020630) Protein [Mass/volume] in Serum or Plasma
148
953
1.62
6.63
2.6
2.9
g/l
63.6
66.3
3.21
129
870
(3024522) Salmonella sp identified in Specimen by Organism specific culture
32
117
2.78
6.57
1.6
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
48
217
2.26
6.35
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
340
2629
1.40
6.21
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
62
314
2.02
6.16
5.2
4.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
972
8837
1.38
6.12
28.5
16.7
%
37.5
39.3
5.34
602
5732
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
820
7262
1.34
6.11
4.2
3.7
pmol/l
15.0
15.0
0.02
719
6430
(3010421) pH of Blood
58
289
2.05
6.03
4.6
4.8
ph
7.4
7.4
0.03
48
245
(46235355) HIV 1 and 2 tests - Meaningful Use set
158
1068
1.54
5.76
1.5
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
464
3818
1.33
5.59
4.6
3.7
e6/l
82.0
125.4
0.84
359
2814
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
57
3.37
5.45
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
57
3.37
5.45
1.6
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
35
148
2.40
5.42
2.6
2.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
48
233
2.10
5.38
3.1
3.5
u/ml
253.6
1698.3
0.74
41
221
(3019060) Gas panel - Arterial blood
120
775
1.60
5.33
6.7
4.5
—
—
—
0
0
(4010399)
115
740
1.61
5.19
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
41
191
2.18
5.10
1.1
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
132
881
1.55
5.10
1.4
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
98
609
1.66
5.08
2.5
3.2
e9/l
3.8
4.1
0.88
57
454
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
110
2.58
5.07
2.0
3.4
%
71.3
57.4
1.73
15
71
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
52
267
1.99
5.03
1.2
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
363
2929
1.33
4.89
3.7
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
40
188
2.16
4.88
1.2
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
182
2.18
4.85
2.8
3.4
%
3.0
1.1
1.09
27
141
(3021589) Normoblasts [#/volume] in Blood
527
4483
1.29
4.81
12.6
10.0
e9/l
0.0
0.0
0.95
436
3649
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
42
3.60
4.77
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
42
3.60
4.77
1.7
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
186
1352
1.44
4.74
1.4
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
27
108
2.53
4.73
3.6
3.9
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
22
79
2.82
4.73
1.4
1.2
nmol/l
357.9
359.7
0.01
17
64
(3022145) Colonoscopy Study observation
145
1005
1.50
4.71
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
207
1536
1.41
4.71
1.4
1.5
g/l
3.1
2.7
1.25
124
906
(3017143) Hepatitis C virus Ab [Presence] in Serum
121
807
1.55
4.70
1.5
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
63
356
1.81
4.59
6.4
6.1
mmol/l
1.4
1.3
0.27
54
311
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
296
2339
1.34
4.56
1.8
1.7
pmol/l
78423698.6
10043158.9
0.64
241
1872
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
49
256
1.95
4.54
1.2
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
48
249
1.96
4.54
4.4
5.1
mmol/l
2.6
2.7
0.08
35
165
(3045424) Erythrocytes [Presence] in Urine
33
148
2.26
4.53
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
583
5051
1.28
4.52
2.7
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
34
155
2.23
4.49
3.2
2.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
974
9009
1.31
4.44
5.2
4.4
mu/l
2.0
2.1
0.56
867
8039
(40768806) Pleura Pathology biopsy report
32
144
2.25
4.36
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
77
470
1.68
4.31
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
570
4945
1.27
4.31
6.0
4.9
estimate
0.0
0.0
0.00
90
964
(36660697) Celiac disease serology panel - Serum
93
596
1.60
4.30
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
120
2.36
4.27
2.6
4.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
37
179
2.10
4.24
1.5
1.4
g/l
33.4
31.8
0.34
32
162
(3005719) IgG [Mass/volume] in Serum or Plasma
103
681
1.56
4.18
1.8
3.0
g/l
10.8
10.6
0.17
93
618
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
103
2.45
4.15
1.2
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
97
2.50
4.14
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
97
2.50
4.14
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
97
2.50
4.14
1.2
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
33
155
2.16
4.08
1.4
1.4
e6/l
1539.4
1626.3
0.07
22
106
(3000492) Spirometry study
117
800
1.51
4.08
1.6
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
574
5007
1.26
4.07
4.2
3.7
estimate
0.0
0.0
0.00
88
927
(3019550) Sodium [Moles/volume] in Serum or Plasma
1120
10612
1.38
4.06
32.7
18.0
mmol/l
139.0
139.7
11.31
1101
10302
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
245
1.91
4.06
1.4
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
58
2.96
4.02
1.2
1.2
u/ml
0.0
2.1
—
10
34
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
99
2.45
3.98
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
566
4940
1.26
3.96
4.2
3.7
estimate
0.0
0.0
0.00
85
962
(40761511) CBC panel - Blood by Automated count
1097
10371
1.35
3.95
25.9
14.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1121
10639
1.37
3.89
32.7
18.2
mmol/l
4.0
4.0
3.20
1099
10312
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
146
2.15
3.82
1.2
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
31
146
2.15
3.82
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
60
2.86
3.80
1.8
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
189
1.99
3.70
1.3
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
17
62
2.76
3.59
1.7
1.2
promille
1.4
1.1
—
10
47
(3030981) Hyaline casts [#/volume] in Urine by Automated count
91
607
1.54
3.58
3.0
2.9
e6/l
0.2
0.4
0.75
91
593
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
142
1035
1.42
3.58
3.1
2.9
ng/l
192.5
226.0
0.52
133
953
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
68
2.67
3.57
1.2
1.2
g/l
3.4
2.9
0.53
13
48
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
111
2.28
3.56
1.2
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
151
1117
1.40
3.50
1.2
1.3
titre
697.6
450.9
0.74
34
231
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
945
1.43
3.50
2.0
1.7
%
1.7
1.5
0.88
106
796
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
31
152
2.06
3.48
1.1
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
81
531
1.56
3.45
1.3
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
29
139
2.11
3.45
1.7
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
72
460
1.60
3.42
1.3
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
437
1.61
3.40
2.8
2.9
g/l
3.9
3.8
0.13
46
325
(3028308) Erythrocytes [#/volume] in Pleural fluid
29
140
2.10
3.39
1.4
1.4
e6/l
14357.0
122391.4
1.37
18
82
(3000330) Specific gravity of Urine by Test strip
84
558
1.54
3.38
4.9
3.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
438
1.61
3.37
2.8
2.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
438
1.61
3.37
2.8
2.9
g/l
7.3
7.4
0.12
48
335
(3026493) Urate [Moles/volume] in Serum or Plasma
338
2821
1.27
3.37
3.1
2.9
umol/l
6502.0
7306.5
0.11
280
2412
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
33
169
1.98
3.31
1.3
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
13
43
3.04
3.25
1.8
2.6
e9/l
0.2
0.2
0.14
13
38
(1761868) Lipid panel - Serum or Plasma
263
3194
0.78
3.24
3.5
3.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
150
2.02
3.21
1.3
1.4
—
—
—
0
0
(4015189)
10
28
3.59
3.20
3.2
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
120
869
1.42
3.16
3.3
3.9
%
1.5
0.8
0.61
37
266
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
406
1.61
3.15
2.8
3.0
g/l
3.1
3.1
0.04
47
329
(40760892) CBC W Ordered Manual Differential panel - Blood
252
2048
1.29
3.10
3.7
4.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
16
5.02
3.05
1.3
1.2
—
—
—
0
0
(4062490)
17
68
2.52
3.05
1.1
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
68
2.52
3.05
1.2
1.2
g/l
7.4
7.8
0.11
12
47
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
68
2.52
3.05
1.2
1.2
g/l
0.8
0.4
0.58
12
48
(3035637) Corticotropin [Mass/volume] in Plasma
23
106
2.19
3.04
1.2
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
197
1.85
3.00
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
39
220
1.80
2.96
1.1
1.1
—
1061.7
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
88
2.29
2.94
1.1
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
22
4.11
2.88
1.0
1.7
—
—
—
0
0
(44790047)
25
122
2.07
2.88
1.2
1.6
—
—
—
0
0
(44806118)
25
122
2.07
2.88
1.2
1.6
—
—
—
0
0
(44790049)
25
122
2.07
2.88
1.2
1.6
—
—
—
0
0
(44790048)
25
122
2.07
2.88
1.2
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
283
2356
1.26
2.85
2.9
2.6
e6/l
5.4
5.1
0.15
246
2089
(3021440) Promyelocytes/100 leukocytes in Blood
113
827
1.40
2.82
3.1
4.0
%
0.2
0.1
0.08
33
248
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
103
2.16
2.81
2.2
1.7
u/l
177.0
2167.5
—
5
33
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
90
2.24
2.81
1.3
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
12
42
2.87
2.75
2.4
2.0
umol/l
57.3
53.6
—
7
34
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
105
2.11
2.69
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
416
1.54
2.66
2.9
2.9
g/l
9.6
10.5
1.00
51
355
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
43
259
1.68
2.63
3.5
2.7
mg/l
1.7
1.8
0.15
35
232
(3006653) Thiamine [Moles/volume] in Blood
13
49
2.67
2.62
1.2
1.2
nmol/l
107.2
136.6
1.51
13
49
(3011397) Hemoglobin [Presence] in Urine by Test strip
281
2362
1.24
2.58
4.2
3.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
56
2.52
2.53
1.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
56
2.52
2.53
1.2
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
56
2.52
2.53
1.2
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
56
2.52
2.53
1.2
1.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
77
539
1.46
2.48
1.5
2.0
g/l
1.2
1.6
1.66
69
489
(3009871) Measles virus Ab [Titer] in Serum
7
16
4.39
2.47
1.3
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
21
3.83
2.46
2.1
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
123
1.97
2.46
1.1
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
45
2.68
2.45
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
27
145
1.88
2.43
2.4
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
60
405
1.50
2.33
2.0
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
141
1.86
2.28
1.3
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
16
72
2.24
2.28
3.7
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
239
1.65
2.27
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
239
1.65
2.27
1.5
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
18
3.90
2.25
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
79
2.17
2.25
1.1
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
104
783
1.36
2.23
2.6
2.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
29
3.12
2.22
1.1
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
128
1.89
2.22
4.7
4.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
53
354
1.52
2.17
3.2
2.7
g/l
36.5
37.1
0.29
42
306
(3024980) IgG subclass 4 [Mass/volume] in Serum
22
115
1.93
2.16
1.2
1.4
g/l
0.9
0.9
0.09
14
88
(3045788) Cell count panel - Pleural fluid
24
130
1.86
2.13
1.4
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
15
68
2.22
2.11
1.3
2.0
mmol/l
6.4
7.5
—
10
41
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
238
1.61
2.06
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
54
368
1.49
2.03
3.1
3.1
g/l
0.6
1.6
1.27
45
321
(3044290) Cell count panel - Cerebral spinal fluid
30
178
1.70
2.00
1.2
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
21
3.35
1.96
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
14
64
2.20
1.94
1.6
1.3
ml
1987.3
1562.1
—
7
10
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
16
3.76
1.93
1.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
157
1.73
1.93
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
307
1.52
1.92
1.8
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
46
308
1.51
1.90
3.5
3.0
g/l
0.0
0.0
0.00
41
288
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
93
1.95
1.85
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
46
2.40
1.85
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
46
2.40
1.85
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
59
2.22
1.84
1.3
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
17
3.54
1.84
1.7
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
27
160
1.70
1.82
1.3
1.4
—
16.1
—
0
5
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
130
1.78
1.82
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
64
462
1.41
1.81
8.7
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
199
1.62
1.81
1.3
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
48
328
1.48
1.81
3.4
2.9
g/l
0.0
0.0
0.01
43
303
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1107
10710
1.21
1.81
14.1
10.5
u/l
23.8
26.0
5.06
1068
10238
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
46
312
1.49
1.80
3.5
2.9
g/l
0.0
0.0
0.49
41
289
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
172
1427
1.24
1.80
12.0
7.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
29
2.77
1.79
4.5
2.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
60
2.18
1.78
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
49
339
1.46
1.75
1.1
1.0
—
—
—
0
0
(4198724)
6
18
3.34
1.74
1.7
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
30
2.68
1.72
1.3
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
24
2.93
1.72
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
14
68
2.07
1.70
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
89
1.92
1.70
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
204
1.58
1.66
1.5
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
19
3.17
1.66
1.7
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
127
1.74
1.64
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
76
1.98
1.64
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
990
9510
1.17
1.64
24.9
14.9
ml/min/173m2
77.8
75.8
1.95
865
7846
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
147
1214
1.24
1.62
4.9
3.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
128
1.73
1.61
3.0
2.4
mg/l
33.8
26.6
—
6
31
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
175
1474
1.22
1.60
1.3
1.2
iu/ml
45.7
42.1
0.09
57
453
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
63
2.07
1.60
2.6
1.4
—
73.5
—
0
6
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
70
2.01
1.59
1.3
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
20
3.01
1.58
1.2
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
207
1.56
1.58
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
20
114
1.77
1.57
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
135
1111
1.24
1.54
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
43
0.00
1.52
0.0
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
36
242
1.50
1.51
1.8
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
51
2.17
1.50
1.2
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
14
72
1.95
1.49
1.8
2.3
e9/l
0.8
1.1
—
5
45
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
52
2.12
1.44
2.4
2.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
16
3.13
1.44
3.0
5.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
133
1.67
1.43
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
98
785
1.27
1.43
3.3
4.0
%
0.0
0.1
0.96
26
208
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
40
2.26
1.40
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
74
1.90
1.39
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
142
1.63
1.39
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
206
1.52
1.38
1.3
1.4
nmol/l
0.6
0.8
1.88
22
170
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
41
2.20
1.37
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
41
2.20
1.37
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
39
0.00
1.34
0.0
1.2
—
68.4
—
0
33
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
114
939
1.23
1.32
5.6
3.9
mmol/l
1.2
1.2
0.04
107
811
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
64
492
1.32
1.29
4.0
3.4
pmol/l
4.2
4.4
1.26
53
428
(3004616) Nuclear Ab [Presence] in Serum
17
99
1.73
1.27
1.1
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
44
2.05
1.27
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
584
0.73
1.26
1.6
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
56
424
1.34
1.26
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
92
1.75
1.25
1.2
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
96
783
1.24
1.23
2.7
3.8
%
0.9
0.6
0.47
24
191
(3035320) C reactive protein [Mass/volume] in Body fluid
12
63
1.91
1.23
2.5
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
63
1.91
1.23
1.8
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
78
1.80
1.21
2.4
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
189
1.49
1.19
1.8
1.7
iu/l
2.3
5.0
2.05
11
56
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
61
472
1.31
1.19
1.2
1.2
iu/ml
229.7
143.4
0.36
17
171
(3020682) Albumin/Creatinine [Ratio] in Urine
389
3571
1.13
1.19
3.9
4.0
mg/mmol
8.0
8.6
0.13
263
2270
(3019150) Specific gravity of Urine by Refractometry
245
2183
1.15
1.18
5.2
4.1
kg/l
1.0
1.0
0.10
53
310
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
38
2.11
1.18
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
64
1.88
1.18
1.3
1.0
u/ml
3.3
4.1
—
7
19
(21494755) Public health laboratory ask at order entry panel
41
553
0.73
1.16
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
102
1.68
1.16
1.1
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
395
1.33
1.16
3.0
4.0
mg/l
45.0
56.4
0.74
46
319
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
395
1.33
1.16
3.0
4.0
mg/l
28.8
52.1
0.98
46
321
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
87
1.73
1.15
1.1
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1133
11080
1.16
1.12
39.3
22.4
e9/l
257.2
240.9
11.69
1116
10719
(3049717) Cytology report of Urine Cyto stain
65
512
1.28
1.12
2.8
2.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
76
938
0.80
1.12
1.5
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
290
2624
1.14
1.12
3.9
3.5
—
—
—
0
0
(4146454)
19
119
1.61
1.12
2.4
2.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
1133
11082
1.16
1.11
39.1
22.3
fl
91.1
91.6
2.82
1119
10854
(3035941) MCH [Entitic mass]
1133
11083
1.16
1.11
39.1
22.3
pg
30.1
30.5
6.99
1118
10855
(3026361) Erythrocytes [#/volume] in Blood
1133
11084
1.16
1.10
39.2
22.4
e12/l
4.3
4.5
18.35
1110
10685
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
66
1.83
1.09
1.8
2.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1133
11086
1.16
1.09
39.3
22.4
e9/l
7.2
6.8
3.01
1112
10685
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
41
1.96
1.09
1.3
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1133
11087
1.16
1.08
39.4
22.5
g/l
128.1
135.2
38.15
1119
10858
(3021901) Oxygen saturation in Capillary blood
31
219
1.43
1.07
2.5
2.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
412
3817
1.12
1.07
4.8
4.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
33
2.13
1.05
2.3
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
39
289
1.36
1.04
2.6
4.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
35
2.01
1.00
5.1
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
76
1.72
0.99
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
2787
0.89
0.98
2.9
3.2
ug/l
0.8
0.8
0.07
176
1917
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
245
2704
0.88
0.98
1.6
1.6
mmol/l
1.4
1.4
0.46
217
2210
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
84
1.67
0.98
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
27
190
1.43
0.97
1.3
1.2
u/l
19.3
33.1
0.76
22
164
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
36
1.95
0.97
1.3
1.1
—
66.4
—
0
7
(40768800) Prostate Pathology biopsy report
22
318
0.69
0.96
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
34
250
1.37
0.96
2.6
2.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
276
1.35
0.96
1.5
1.6
iu/ml
0.1
2.7
—
6
53
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
32
233
1.38
0.96
1.4
1.3
mg/l
630.3
551.7
0.20
32
218
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
51
1.77
0.94
1.1
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
85
1.65
0.94
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
62
1.78
0.94
7.3
17.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
109
930
1.19
0.94
5.0
3.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
52
1.74
0.92
1.7
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
28
2.15
0.91
1.7
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
245
1.36
0.89
3.0
2.6
%
14.3
15.8
1.02
19
120
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
29
2.07
0.89
1.5
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
50
395
1.28
0.89
1.3
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
42
1.91
0.88
1.4
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
42
1.91
0.88
1.4
2.2
—
—
—
0
0
(4034850)
25
346
0.72
0.88
12.8
10.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
281
1.33
0.87
1.5
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
43
1.87
0.87
1.4
2.2
—
—
—
0
0
(4027681)
8
43
1.87
0.87
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
265
1.33
0.85
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
846
8185
1.09
0.84
35.4
20.1
g/l
330.1
332.3
8.57
836
8104
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
31
1.94
0.84
3.0
3.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
179
1.40
0.84
4.4
5.6
iu/ml
202.4
1015.9
—
5
29
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
34
257
1.33
0.83
1.3
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
146
1.45
0.82
1.2
1.3
miu/ml
102.3
205.7
—
8
62
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
387
0.74
0.82
1.2
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
258
1.33
0.82
1.3
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
24
0.00
0.79
0.0
2.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
2.2
—
2.6
—
0
12
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
8
48
1.67
0.78
1.0
1.1
—
8.1
—
0
11
(40768795) Lymph node Pathology biopsy report
15
98
1.54
0.78
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
34
261
1.31
0.77
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
53
1.70
0.75
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
50
405
1.24
0.75
1.5
1.9
u/l
41.1
38.9
0.30
37
342
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
11
67
1.65
0.75
1.0
1.0
mg/l
278.5
297.6
0.43
11
55
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
54
1.67
0.74
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
843
8179
1.09
0.74
33.2
18.8
%
14.3
13.8
12.85
828
7962
(3020650) Glucose [Presence] in Urine
5
25
2.00
0.72
1.6
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
775
7498
1.08
0.72
5.4
4.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
84
1.55
0.72
1.3
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
16
109
1.47
0.71
1.2
1.2
mmol/l
9.1
7.8
0.47
11
77
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
101
1.49
0.70
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
486
0.80
0.69
1.8
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
135
1.41
0.69
1.3
1.2
u/ml
343.7
284.6
0.40
12
81
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
27
1.85
0.68
8.4
7.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
42
1.67
0.68
2.1
3.4
u/l
255.3
205.0
—
7
42
(21494890) Protein electrophoresis panel - 24 hour Urine
18
127
1.42
0.68
1.3
2.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
43
1.63
0.67
1.1
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
156
1409
1.12
0.66
1.3
1.2
u/ml
11.5
13.1
0.09
45
526
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
13
86
1.52
0.66
2.5
2.3
ml
682.9
659.3
—
7
54
(3047189) Immunofixation for 24 hour Urine
10
62
1.62
0.65
1.5
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
16
224
0.71
0.64
1.4
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
63
1.59
0.62
4.2
3.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
8
50
1.60
0.61
1.3
1.0
u/ml
10.0
1.0
—
8
19
(1002224) Polysomnography panel
24
312
0.76
0.61
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.1
—
1.4
—
0
13
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
17
122
1.40
0.60
1.3
2.0
u/ml
3.3
107.8
0.52
17
114
(3011288) Drugs identified in Urine by Screen method
14
97
1.45
0.59
3.4
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
64
1.57
0.58
4.9
3.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
35
1.72
0.57
1.2
2.5
—
52898.8
—
0
9
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
54
1.48
0.57
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
852
1.14
0.56
4.3
2.9
ml/min/173m2
64.3
63.5
0.06
35
356
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
55
1.46
0.56
1.6
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
43
357
1.21
0.55
1.4
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
39
321
1.22
0.55
1.1
1.1
—
247.5
—
0
8
(4306422)
8
125
0.64
0.54
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
60
1.50
0.54
2.0
3.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
261
0.76
0.54
2.3
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
295
1.23
0.53
2.4
2.3
ug/min
33.4
94.5
1.02
19
166
(4024509)
13
91
1.43
0.53
1.4
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
63
1.43
0.52
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
63
1.43
0.52
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
446
0.82
0.52
1.8
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
20
152
1.32
0.52
2.4
2.1
%
90.4
89.8
0.20
20
152
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
156
0.70
0.50
1.3
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
10
67
1.50
0.49
2.2
2.1
min
524.6
492.3
—
5
44
(3037121) Protein [Mass/volume] in Urine
45
382
1.18
0.48
3.4
3.0
g/l
0.3
0.2
0.64
27
158
(3051387) C reactive protein [Mass/volume] in Capillary blood
20
256
0.78
0.48
2.8
3.8
mg/l
34.4
28.3
0.34
13
176
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
27
217
1.25
0.48
1.0
1.2
u/ml
2.8
8.6
—
5
32
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
128
1.33
0.47
2.1
1.6
%
80.8
60.2
3.44
12
79
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
31
254
1.23
0.47
1.2
2.1
mg/l
13.5
12.3
0.13
25
231
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
11
77
1.43
0.45
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
292
1.20
0.45
3.3
3.0
nmol/l
0.8
0.8
0.02
23
230
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
963
9468
1.06
0.45
4.3
4.1
mmol/l
1.3
1.3
0.12
863
8440
(3044242) Glucose [Moles/volume] in Arterial blood
10
69
1.45
0.44
2.0
2.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
202
1.24
0.43
2.0
3.5
%
63.8
58.7
1.09
25
202
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
95
0.63
0.42
1.3
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
206
0.77
0.41
1.4
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
296
1.19
0.40
1.3
1.7
mg/l
4.1
3.2
0.23
27
217
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
34
1.47
0.40
1.2
1.6
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.1
—
1.2
—
0
12
(3003740) Influenza virus B Ag [Presence] in Specimen
13
97
1.34
0.39
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1010
9960
1.06
0.39
5.2
4.8
mmol/l
6.1
6.1
0.28
913
8872
(3037756) Immunofixation for Serum or Plasma
31
261
1.19
0.38
1.7
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
9
66
1.37
0.38
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
68
1.33
0.37
1.8
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
234
1.20
0.37
2.3
2.2
g/l
120.3
129.2
1.09
22
179
(3002523) Influenza virus A Ag [Presence] in Specimen
13
98
1.33
0.37
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
9
69
1.31
0.37
2.1
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
90
1.34
0.36
1.8
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
124
0.72
0.35
1.1
1.1
—
—
—
0
0
(4268621)
6
88
0.68
0.33
2.3
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
351
3387
1.05
0.32
3.3
3.3
mg/l
343.7
262.8
0.14
245
2187
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
7
96
0.73
0.31
1.1
1.1
%
81.0
92.9
—
7
91
(3000475) Leukocytes [#/volume] in Synovial fluid
23
271
0.85
0.29
1.8
1.7
e6/l
36217.0
15432.1
0.73
16
195
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
194
1.19
0.29
1.9
3.2
e9/l
5.3
4.5
0.54
23
194
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
94
1.28
0.28
1.4
1.6
%
9.3
10.8
0.77
12
94
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
62
1.29
0.28
2.0
1.3
—
500.0
—
0
6
(3009508) Creatinine [Moles/volume] in Urine
357
3460
1.04
0.27
3.3
3.2
mmol/l
7.0
7.6
1.77
293
2869
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
945
9561
0.96
0.27
7.1
6.2
mmol/mol
40.9
40.5
0.48
854
8696
(3017704) Immunofixation for Urine
5
71
0.70
0.26
2.0
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
188
1.17
0.25
1.0
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
22
188
1.17
0.25
2.8
2.0
mmol/l
1.4
1.7
0.85
22
182
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
105
1.24
0.25
1.5
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
198
1.16
0.24
1.1
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
161
1.18
0.24
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
178
0.84
0.22
1.5
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
37.6
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
6
48
1.25
0.20
1.2
1.2
—
0.1
—
0
6
(3016879) Cocaine [Presence] in Urine
16
136
1.18
0.20
4.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
146
1.17
0.19
4.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
53
1.13
0.18
7.3
7.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
269
0.89
0.18
1.1
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
7
63
1.11
0.17
1.1
1.1
—
4.7
—
0
15
(3028300) Cannabinoids [Presence] in Urine
17
148
1.15
0.17
4.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
148
1.15
0.17
4.0
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
68
1.18
0.16
1.3
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
68
1.18
0.16
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
382
3894
0.97
0.16
4.0
4.5
%
21.5
21.9
0.22
185
2030
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
317
0.91
0.15
1.9
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
103
1.17
0.13
1.6
1.2
nmol/l
0.7
0.7
0.31
12
98
(3021788) Differential panel - Synovial fluid
22
199
1.11
0.13
1.7
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
272
2775
0.98
0.13
4.6
4.0
estimate
0.0
0.0
0.50
85
898
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
123
1.14
0.12
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
115
1.13
0.10
1.5
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
96
1.15
0.10
1.6
1.2
—
—
—
0
0
(4094501)
27
251
1.08
0.10
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
125
1.12
0.10
1.2
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
28
261
1.07
0.10
1.3
1.7
nmol/l
45.9
41.7
0.47
28
248
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
46
1.09
0.09
1.0
1.6
umol/l
19.0
5.4
—
5
26
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
2.2
1.6
g/l
1.2
0.9
—
5
47
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
472
0.95
0.09
1.4
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
126
1.11
0.09
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
55
1.09
0.09
1.3
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
107
1.12
0.08
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1010
10140
0.98
0.08
5.1
5.2
mmol/l
2.5
2.6
2.22
916
9139
(3023511) Choriogonadotropin [Units/volume] in Urine
5
60
0.83
0.08
1.6
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
146
1.10
0.08
4.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
69
667
1.04
0.08
2.8
3.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
28
265
1.06
0.07
1.0
1.4
g/l
0.2
0.2
0.16
23
252
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
183
0.93
0.06
1.4
1.4
—
—
—
0
0
(4281824)
11
99
1.11
0.06
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
148
1.08
0.06
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
88
899
0.98
0.05
3.2
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
987
9897
0.99
0.05
4.6
4.6
mmol/l
4.4
4.5
1.47
901
8975
(3008898) HLA-B27 [Presence]
23
242
0.95
0.05
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
982
9800
1.01
0.03
4.7
4.6
mmol/l
1.4
1.4
0.47
889
8811
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
481
4831
0.99
0.03
4.9
5.2
ug/l
2.2
4.2
1.49
420
4286
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
28
273
1.03
0.01
1.0
1.4
g/l
1.2
1.2
0.23
23
260
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
156
0.96
0.00
2.1
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
124
0.97
0.00
1.9
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
196
1.02
0.00
1.9
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
92
924
1.00
0.00
1.5
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
169
1.01
0.00
1.9
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
221
1.00
0.00
2.7
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
7.8
—
10.2
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
49
1.02
0.00
2.4
1.7
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
82
0.98
0.00
4.2
4.0
u/ml
23.4
64.1
—
8
82
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
84
840
1.00
0.00
2.0
2.1
nmol/l
11.1
12.5
0.88
76
732
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
181.3
—
0
7
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
18.3
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
180
1.00
0.00
2.3
3.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
85
0.94
0.00
1.5
1.2
nmol/l
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(4211845)
5
53
0.94
0.00
1.2
2.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
6
61
0.98
0.00
3.2
2.0
mmol/l
9.3
10.0
—
6
49
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OESOBST and mortality.

Females

Parameter HR [95% CI] p-value
K11_OESOBST 2.105 [1.86, 2.38] < 0.001
Birth year 0.991 [0.98, 1.0] 0.039

During the follow-up period (1.1.1998 — 31.12.2019), 1435 out of 3155 females with K11_OESOBST died.

Males

Parameter HR [95% CI] p-value
K11_OESOBST 2.364 [2.09, 2.68] < 0.001
Birth year 0.991 [0.98, 1.0] 0.041

During the follow-up period (1.1.1998 — 31.12.2019), 2067 out of 4493 males with K11_OESOBST died.

Mortality risk

Mortality risk for people of age

years, who have K11_OESOBST.

N-year risk Females Males
1 0.172% 0.425%
5 1.071% 2.722%
10 2.621% 7.782%
15 5.238% 14.343%
20 9.321% 23.381%

Relationships between endpoints

↥

Index endpoint: K11_OESOBST – Oesophageal obstruction

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data